Skip to content

Postoperative Desogestrel for Endometriosis Related Pain

A Prospective Double Blind Randomized Controlled Trial to Study the Effectiveness of a Desogestrel for the Treatment of Pelvic Pain or Dysmenorrhea in the Patients Undergone Conservative Surgery for Pelvic Endometriosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01559480
Enrollment
40
Registered
2012-03-21
Start date
2012-01-31
Completion date
2014-10-31
Last updated
2015-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Keywords

Endometriosis, Desogestrel, Placebo

Brief summary

Endometriosis is one of the most common disease in reproductive aged women.Surgical intervention has a significant symptoms relief. However, symptom recurrence is often after surgery. This study aims to determine the efficacy of Desogestrel compared with placebo in pain symptom of symptomatic endometriosis patient undergo conservative surgery . The primary outcome measurement is pain score at 6 months after surgery.

Detailed description

After conservative surgery, the patients are randomized to Desogestrel and placebo groups. VAS pain score are compared after complete 6 months

Interventions

Desogestrel 75 mcg Takes 1 capsule before bedtime for 6 months

DRUGPlacebo

Placebo capsule takes 1 capsule before bedtime for 6 months

Sponsors

Mahidol University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* diagnoses endometriosis * Plan conservative surgery * initial pain score at least 5 * voluntary to be the participant of this study with inform consent * No desired child bearing in 6 months

Exclusion criteria

* residual lesion after surgery which required further treatment * cannot participate complete 6 months after surgery * contraindication for Desogestrel, Paracetamol or Ponstan * Pregnant

Design outcomes

Primary

MeasureTime frameDescription
Pain score6 monthsPain score will be assessed by visual analog scale (0-10)

Secondary

MeasureTime frame
Side effect compared between both group6 month
Patients satisfaction compare between both groups6 months

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026